The ministry said in a statement that the vaccine developed by Pfizer and BioNTech, whose final trial results showed it had a 95% success rate and no serious side effects, will be delivered next year.
from Hindustan Times - world https://ift.tt/3gpp2FE
No comments:
Post a Comment